Business brief
Teva Advances Drug Pipeline as Defense Tech Drives Real Estate Demand
Teva secures clinical funding for celiac treatment, while defense tech hiring reshapes Tel Aviv commercial real estate.
Business
PayPal's Tel Aviv cuts show global tech leaders are stripping out regional overhead — reallocating core engineering payroll directly into generative AI infrastructure.
BackgroundPayPal established a major R&D footprint in Tel Aviv following past acquisitions in fraud prevention and security. Global management is trimming overall headcount to redirect corporate resources toward localized artificial intelligence capabilities and checkout automation.
- The Tel Aviv layoffs eliminate 70 of PayPal's 300 local positions across software development and risk operations, shrinking its local engineering footprint.
- PayPal expects the global headcount reduction of 4,760 roles to yield $1.5 billion in annualized operational savings across its technology division.
- Capital saved from corporate workforce cuts is being redirected into localized generative AI models and simplified checkout interfaces to reverse slowing transaction growth.
Business
Teva's celiac win validates its pivot toward innovative biologics — securing $500 million in funding to build a high-margin proprietary drug pipeline.
BackgroundTeva is executing its Pivot to Growth strategy under CEO Richard Francis to rebuild its innovative pipeline following legacy generic price pressures. Celiac disease currently lacks approved disease-modifying biologic treatments, making TEV '408 a potential first-in-class therapy.
- TEV '408 achieved statistically significant prevention of gluten-induced mucosal damage in adult celiac patients, proving biological activity in Phase 2a trials.
- Royalty Pharma is providing up to $500 million in clinical funding to accelerate Phase 2b and Phase 3 trials, shifting development risk away from Teva.
- Teva submitted a court-supervised bid to acquire BioXcel's sublingual neuroscience film asset, expanding its central nervous system portfolio at a distressed valuation.
Business
Defense-tech growth has absorbed Tel Aviv office vacancies — replacing downsized foreign software teams with expanding domestic security contractors.
BackgroundTel Aviv commercial real estate faced prolonged vacancy pressure over the past two years due to global tech downsizing and local macroeconomic instability. Domestic defense startups have rapidly scaled hiring to meet surging military demand, transforming local real estate dynamics.
- Class A office occupancy across central Tel Aviv reached 99% in early 2026, eliminating remaining prime floor space along commercial corridors.
- Rental rates along Menachem Begin Road rose 3% to ₪151 per square meter as expanding firms competed for contiguous office floors.
- Surging defense and security hiring absorbed commercial space vacated by downsizing foreign software vendors, shifting market reliance toward domestic government contractors.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
